Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: EXercise and Activin Inhibition to Modulate InflammatioN Effects on Heart Failure and Cognition (EXAMINE-HFC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating exercise plus activin inhibition to modulate inflammation effects in heart failure with preserved ejection fraction. The study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Activin inhibitor (activin inhibitor)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: NOT_YET_RECRUITING